Rapid Reviews Infectious Diseases
RR\ID (Rapid Reviews\Infectious Diseases) is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints.
Latest preprint reviews
-
Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes
This article has 5 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
GRP78 binds SARS-CoV-2 Spike protein and ACE2 and GRP78 depleting antibody blocks viral entry and infection in vitro
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Structural and Functional Comparison of SARS-CoV-2-Spike Receptor Binding Domain Produced in Pichia pastoris and Mammalian Cells
This article has 31 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA
This article has 4 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
This article has 12 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
This article has 12 authors:Reviewed by ScreenIT, Rapid Reviews Infectious Diseases
-
Inhibition of SARS-CoV-2 infection in human cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoskeleton architecture and contractility
This article has 26 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
This article has 24 authors:Reviewed by Rapid Reviews Infectious Diseases, PREreview, ScreenIT
-
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
This article has 25 authors:Reviewed by ScreenIT, Rapid Reviews Infectious Diseases
-
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
This article has 24 authors:Reviewed by ScreenIT, Rapid Reviews Infectious Diseases